Browsing Tag
CNS drug delivery
2 posts
Is delivery, not biology, the real key to Alzheimer’s breakthroughs? Lunai Bioworks Inc. is testing it
Can Lunai Bioworks Inc. solve Alzheimer’s drug delivery challenges? Discover what its BBB platform means for CNS innovation and investor outlook.
JR-446 developed by JCR Pharmaceuticals secures orphan drug designation from the European Commission for MPS IIIB
The European Commission has granted orphan drug status to JR-446 for MPS IIIB, supporting JCR Pharmaceuticals’ global rare disease expansion.